title: Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA. Electronic address: motzerr@mskcc.org.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Motzer
authors.affiliation: Texas Oncology, Dallas, TX, USA.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Hutson
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Ren
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: Corina
authors.initials: C
authors.lastname: Dutcus
authors.affiliation: Royal Marsden Hospital NHS Foundation Trust, London, UK.
authors.forename: James
authors.initials: J
authors.lastname: Larkin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000556:secondary; D018572:Disease-Free Survival; D000068338:Everolimus / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D010671:Phenylurea Compounds / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D066066:Response Evaluation Criteria in Solid Tumors; D012189:Retrospective Studies; D016037:Single-Blind Method; D014057:Tomography, X-Ray Computed
chemical_list: D010671:Phenylurea Compounds; D011804:Quinolines; D000068338:Everolimus; C531958:lenvatinib